Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak

@xconomy.com 4 years ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 5 years ago

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

@xconomy.com 5 years ago

GrainChain, Chargify, Q2, Hypergiant, NASA Tech & More TX Tech

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 5 years ago

Upland Software, Bumble in India, Cratejoy Layoffs, & More TX Tech

@xconomy.com 5 years ago

Exits in Austin, Pitch NASA, Diversity in Energy, & More TX Tech

@xconomy.com 5 years ago

OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million